# Vinorelbine

## Navelbine 20mg

##### 臨採

| TAH Drug Code      | [ONAV2](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ONAV2)                                                                                                                                                                                                                                                                                                                                                                                    |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Non-small cell lung cancer. Metastatic breast cancer.                                                                                                                                                                                                                                                                                                                                                                                                     |
| Dosing             | As a single agent, first three administrations: 60 mg/m2 once weekly. Beyond the third administration, it is recommended to increase the dose to 80mg/m2 once weekly except in those patients for whom the neutrophil count dropped once < 500/mm3 or 500-1000/mm3 during the first three administrations at 60mg/m2                                                                                                                                      |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Contraindications  | Disease significantly affecting absorption; previous significant surgical resection of stomach or small bowel. Severe hepatic impairment; pregnancy & lactation; patients requiring long-term O2 therapy. Coadministration with meningocococal conjugate vaccine or other live virus vaccines, phenytoin & itraconazole. Pretreatment granulocyte counts <1000/mm3                                                                                        |
| Adverse Effects    | Neutropenia, anemia, thrombocytopenia; nausea & vomiting, diarrhea, anorexia, stomatitis, esophagitis; loss of tendon reflexes, neuromotor disorders, neuroconstipation (rarely progressing to paralytic ileus); alopecia; fatigue, fever, arthralgia including jaw pain, myalgia, pain including pain at tumor site. Vial Ischemic cardiac disease (rare), abnormal liver function tests, dyspnea, bronchospasm, generalized cutaneous reactions (rare). |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Risk                                                                                                                                                                                                                                                                                                                                                                                                        |
| Lactation          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| More Info          | [UpToDate](https://www.uptodate.com/contents/vinorelbine-drug-information)                                                                                                                                                                                                                                                                                                                                                                                |

## NAVELBINE 30mg

| TAH Drug Code      | [ONAV3](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ONAV3)                                                                                                                                                                                                                                                                                                                                                                                    |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Non-small cell lung cancer. Metastatic breast cancer.                                                                                                                                                                                                                                                                                                                                                                                                     |
| Dosing             | As a single agent, first three administrations: 60 mg/m2 once weekly. Beyond the third administration, it is recommended to increase the dose to 80mg/m2 once weekly except in those patients for whom the neutrophil count dropped once < 500/mm3 or 500-1000/mm3 during the first three administrations at 60mg/m2.                                                                                                                                     |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Contraindications  | Disease significantly affecting absorption; previous significant surgical resection of stomach or small bowel. Severe hepatic impairment; pregnancy & lactation; patients requiring long-term O2 therapy. Coadministration with meningocococal conjugate vaccine or other live virus vaccines, phenytoin & itraconazole. Pretreatment granulocyte counts <1000/mm3                                                                                        |
| Adverse Effects    | Neutropenia, anemia, thrombocytopenia; nausea & vomiting, diarrhea, anorexia, stomatitis, esophagitis; loss of tendon reflexes, neuromotor disorders, neuroconstipation (rarely progressing to paralytic ileus); alopecia; fatigue, fever, arthralgia including jaw pain, myalgia, pain including pain at tumor site. Vial Ischemic cardiac disease (rare), abnormal liver function tests, dyspnea, bronchospasm, generalized cutaneous reactions (rare). |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Risk                                                                                                                                                                                                                                                                                                                                                                                                        |
| Lactation          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| More Info          | [UpToDate](https://www.uptodate.com/contents/vinorelbine-drug-information)                                                                                                                                                                                                                                                                                                                                                                                |

